Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Kwiatkowski

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
American Journal of Clinical Oncology|June 1, 1997
Adjuvant chemotherapy with doxorubicin-containing regimen for 326 stage II breast cancers: 15-year resultsJ P Ferrière, S Charrier, H Curé, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 11, 2015
Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trialJ Talvas, G Garrait, N Goncalves-Mendes, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 4, 2017
[Description of the GORTEC 2017-03 study: Postoperative stereotactic radiotherapy for early stage oropharyngeal and oral cavity cancer with high risk margin (PHRC-K-16-164)]J Biau, J Miroir, C Millardet, et al.
British Journal of Cancer|February 20, 2003
Clinical implications of quantitative real-time RT-PCR analysis of hTERT gene expression in human gliomasA Tchirkov, C Rolhion, J-L Kémény, et al.
The British Journal of Surgery|April 13, 2017
Quality of life after mastectomy with or without immediate breast reconstructionJ Dauplat, F Kwiatkowski, P Rouanet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Neoadjuvant chemotherapy in 126 operable breast cancersE Bélembaogo, V Feillel, P Chollet, et al.
Oncology Research|March 25, 2006
Does survival increase in metastatic breast cancer with recently available anticancer drugs?C Abrial, M Leheurteur, A Cabrespine, et al.
Breast (Edinburgh, Scotland)|August 20, 2011
Late lines of treatment benefit survival in metastatic breast cancer in current practice?E Planchat, C Abrial, E Thivat, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: univariate and multivariate analysisJ Attia-Sobol, J P Ferrière, H Curé, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 14, 2019
[Tolerance of hypofractionated stereotactic radiotherapy for hepatic tumours]M Le Bon, M Lapeyre, J Moreau, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
American Journal of Clinical Oncology|June 1, 1997
Adjuvant chemotherapy with doxorubicin-containing regimen for 326 stage II breast cancers: 15-year resultsJ P Ferrière, S Charrier, H Curé, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 11, 2015
Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trialJ Talvas, G Garrait, N Goncalves-Mendes, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 4, 2017
[Description of the GORTEC 2017-03 study: Postoperative stereotactic radiotherapy for early stage oropharyngeal and oral cavity cancer with high risk margin (PHRC-K-16-164)]J Biau, J Miroir, C Millardet, et al.
British Journal of Cancer|February 20, 2003
Clinical implications of quantitative real-time RT-PCR analysis of hTERT gene expression in human gliomasA Tchirkov, C Rolhion, J-L Kémény, et al.
The British Journal of Surgery|April 13, 2017
Quality of life after mastectomy with or without immediate breast reconstructionJ Dauplat, F Kwiatkowski, P Rouanet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Neoadjuvant chemotherapy in 126 operable breast cancersE Bélembaogo, V Feillel, P Chollet, et al.
Oncology Research|March 25, 2006
Does survival increase in metastatic breast cancer with recently available anticancer drugs?C Abrial, M Leheurteur, A Cabrespine, et al.
Breast (Edinburgh, Scotland)|August 20, 2011
Late lines of treatment benefit survival in metastatic breast cancer in current practice?E Planchat, C Abrial, E Thivat, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: univariate and multivariate analysisJ Attia-Sobol, J P Ferrière, H Curé, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 14, 2019
[Tolerance of hypofractionated stereotactic radiotherapy for hepatic tumours]M Le Bon, M Lapeyre, J Moreau, et al.
Pageof 12